Entrada Therapeutics Inc (TRDA:NASDAQ)

$12.58 0.96 (8.26%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 89

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Entrada Therapeutics Inc (TRDA:NASDAQ) News Sources

Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Xeris Pharmaceuticals (XERS)

The Globe and Mail

external link

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kyntra Bio (KYNB) and Silence Therapeutics (SLN)

The Globe and Mail

external link
TRDA stock
TRDA stock price
TRDA stock price today
TRDA stock prediction
TRDA earnings date
TRDA news
TRDA price
TRDA share
TRDA share price
TRDA shares
TRDA ceo
TRDA premarket
$TRDA
TRDA ticker
TRDA after hours
TRDA stock
TRDA stock price
TRDA stock price today
TRDA stock prediction
TRDA earnings date
TRDA news
TRDA price
TRDA share
TRDA share price
TRDA shares
TRDA ceo
TRDA premarket
$TRDA
TRDA ticker
TRDA after hours

Entrada Therapeutics Inc (TRDA:NASDAQ) FAQs

toggle

What is the current price of Entrada Therapeutics Inc (TRDA:NASDAQ)?

The current price of Entrada Therapeutics Inc (TRDA:NASDAQ) is $12.58.


toggle

Entrada Therapeutics Inc (TRDA:NASDAQ) absolute price change since previous trading day?

The absolute price change of Entrada Therapeutics Inc (TRDA:NASDAQ) since the previous trading day is $0.96.


toggle

Entrada Therapeutics Inc (TRDA:NASDAQ) percentage price change since previous trading day?

The percentage price change of Entrada Therapeutics Inc (TRDA:NASDAQ) since the previous trading day is 8.26%.


toggle

What is This Week's average sentiment score for Entrada Therapeutics Inc (TRDA:NASDAQ)?

This Week's average sentiment score for Entrada Therapeutics Inc (TRDA:NASDAQ) is 89 out of 100.


toggle

What is This Week's average sentiment for Entrada Therapeutics Inc (TRDA:NASDAQ)?

This Week's sentiment for Entrada Therapeutics Inc (TRDA:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.